Inventor · disambiguated record
Brenton Mar
Also filed as: MAR BRENTON
1 granted patent·2 pending applications·1 citations·filing 2020–2022
19Inventor score
Files withBLUEPRINT MEDICINES CORP3
Top patents by PatentIndex Score
3 records- 0181US12252494B2Dosing regimens of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine for treatment of indolent systemic mastocytosisBLUEPRINT MEDICINES CORP·Filed 2022·Granted Mar 18, 2025·1 cites·7 claims
- 0237US2024075041A1Treatment of eosinophilic disorders with avapritinibBLUEPRINT MEDICINES CORP·Filed 2020·Application pending·0 cites
- 0334US2022370465A1Treatment of mast cell diseases and eosinophilic disordersBLUEPRINT MEDICINES CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brenton Mar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →